Journal article
Progress in Clinical Neurosciences: Treatment of Alzheimer’s Disease and Other Dementias - Review and Comparison of the Cholinesterase Inhibitors
Abstract
BACKGROUND: Alzheimer's disease (AD) is the most common cause of dementia in older adults. Acceptance of the cholinergic hypothesis led to a search for medications which could enhance central cholinergic activity in this condition. There are now three cholinesterase inhibitors available for the treatment of AD in Canada.
OBJECTIVES: To review the currently available cholinesterase inhibitors approved for the treatment of AD in Canada and to …
Authors
Hogan DB; Patterson C
Journal
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 29, No. 4, pp. 306–314
Publisher
Cambridge University Press (CUP)
Publication Date
November 2002
DOI
10.1017/s031716710000216x
ISSN
0317-1671